FNY Investment Advisers’s Nautilus Biotechnolgy NAUT Stock Holding History

FNY Investment Advisers’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26K	Hold	14,000	–	–	0.01%	498
2026 Q1	$54K	Hold	14,000	–	–	0.02%	355
2025 Q4	$27K	Hold	14,000	–	–	0.01%	531
2025 Q3	$11K	Hold	14,000	–	–	﹤0.01%	786
2025 Q2	$10K	Buy	14,000 +10,000	+250%	+$7.51K	﹤0.01%	662
2025 Q1	$3K	Hold	4,000	–	–	﹤0.01%	623
2024 Q4	$6K	Buy	+4,000	New	+$9.57K	﹤0.01%	526
2022 Q3	–	Sell	-25,600	Closed	-$68K	–	761
2022 Q2	$68K	Sell	25,600 -6,040	-19%	-$22.5K	0.05%	200
2022 Q1	$137K	Buy	31,640 +19,040	+151%	+$78.2K	0.13%	140
2021 Q4	$65K	Buy	+12,600	New	+$67.4K	0.03%	238
2021 Q3	–	Sell	-5,000	Closed	-$50K	–	846
2021 Q2	$50K	Buy	+5,000	New	+$54.2K	0.02%	417

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

FNY Investment Advisers's NAUT Position: Q2 2026 in Review

FNY Investment Advisers held its Nautilus Biotechnolgy (NAUT) position steady in Q2 2026 at 14,000 shares worth $26K. The position accounts for 0.01% of the portfolio, ranked #498.

FNY Investment Advisers first reported a position in NAUT in Q2 2021 and has held it in 11 quarters since. The position peaked at $137K in Q1 2022. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

FNY Investment Advisers held 14,000 shares of Nautilus Biotechnolgy worth $26K as of Q2 2026.
FNY Investment Advisers left its Nautilus Biotechnolgy share count unchanged in Q2 2026.
Nautilus Biotechnolgy made up 0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #498 holding.
FNY Investment Advisers first reported a position in Nautilus Biotechnolgy in Q2 2021 and has held it in 11 quarters since.
FNY Investment Advisers's Nautilus Biotechnolgy position peaked at $137K in Q1 2022.
93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.